Similarly, by the final cycle of dose-intense chemotherapy among patients with breast cancer, several cell types declined compared to pre-chemotherapy levels, including; B cells, CD4+ T cells, CD8+ T cells and NK cells, and the percentage of activated HLA-DR+ T cells increased (Hakim et al., 1997). This evidence concerns the gene CD4 and breast cancer.